Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

Completed · Phase 2 · Has a placebo group

Conditions studied: Mild Cognitive Impairment (MCI)

In brief

This research is being done to find out if daily use of the drug levetiracetam can improve memory function in individuals with memory problems like those associated with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD).

Key facts

Study ID
NCT01044758
Run by
Johns Hopkins University
People needed
96
Starts
2009-12-01
Expected to finish
2012-07-01
Last updated by the study team
2017-08-21

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.